Category: Paragonix Technologies
Paragonix Technologies brings in $1.1 million from a convertible debt financing round.
Paragonix Technologies said it closed $1.1 million in financing via a convertible debt sale round.
The Cambridge, Mass.-based medical device company has brought in $3.4 million through equity, debt financing, and NIH grants, according to a press release.
Paragonix makes an FDA bid to win U.S. marketing clearance for its Sherpa cold perfusion organ transportation systems, aiming to improve out-of-body viability for transplant organs.
Over the last 2 months Massachusetts medtech startup has Paragonix Technologies filed 2 more 510(k) applications in efforts to win U.S. marketing approval for its Sherpa line of heart and kidney transportation systems.
Lisa Maier, president, Paragonix Technologies tells MassDevice how the company is developing a device that will revolutionize the way organs are transported.
Does a donated heart or kidney deserve fancier digs than a ham sandwich? The folks at Paragonix Technologies think so.
The Cambridge Mass.-based startup just landed a $710,000 accelerator loan from the Massachusetts Life Sciences Center to support development efforts for its Sherpa organ transport devices.